Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window

 Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and Company''s code on prohibition of insider trading, the 'Trading Window' for dealing in the securities of the Company shall remain closed for all Designated Persons and their immediate relatives from Friday, 01 July 2022 till the completion of 48 hours after the Unaudited Financial Results of the Company for the quarter ending 30 June 2022 become Generally Available Information. Accordingly, all Designated Persons and their immediate relatives of the Company have been advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window. Kindly take the above information on your record.
29-06-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
27-06-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
27-05-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
25-05-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions for the half year ended 31 March 2022. The above information shall be uploaded on the website of the Company at www.tatvachintan.com. Kindly take the same on your record.
20-05-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Tatva Chintan Pharma Chem Ltd 2 CIN NO. L24232GJ1996PLC029894 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2021-22, 2022-23 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) Nil 8Quantum of (d), which has been met from (c)(e)* Nil 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* Nil Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2020-21, 2021-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Ishwar NayiDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Ashok Bothra Designation : -Chief Financial Officer Date: 11/05/2022
11-05-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
07-05-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, read with SEBI Circular no. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed herewith copy of the Annual Secretarial Compliance Report of the Company issued by M/s. TNT & Associates, Practicing Company Secretaries, Vadodara, Gujarat, India for the financial year ended 31 March, 2022. The above information shall be uploaded on the website of the Company at www.tatvachintan.com. Kindly take the above information on your record.
04-05-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended 31 March 2022, issued by ICICI Bank Limited, appointed to monitor the utilization of proceeds of an Initial Public Offering ('IPO') of the Company. The above information is also being made available on the website of the Company at www.tatvachintan.com. Kindly take the above information on your record.
30-04-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Statement Of Deviation / Variation In Utilization Of Funds Raised Through IPO

 Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed herewith statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended 31 March 2022 in the prescribed format. The same will be filed in XBRL mode separately. We confirm that, as at 31 March 2022, there has not been any deviation(s) or variation(s) in the utilization of net proceeds of IPO as mentioned in the objects stated in the Prospectus dated 22 July 2021. Report issued by Monitoring agency report is being separately filed with the exchange. The above information is also being made available on the website of the Company at www.tatvachintan.com. Kindly take the above information on your record.
30-04-2022
Next Page
Close

Let's Open Free Demat Account